SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-000497
Filing Date
2023-05-10
Accepted
2023-05-10 15:23:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3171
  Complete submission text file 0001950047-23-000497.txt   4463
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37923 | Film No.: 23905925
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Smith Brendan (Reporting) CIK: 0001857492 (see all company filings)

Type: 144